- ►annals.org [PDF] PY Lee, DB Matchar, DA Clements, J Huber, … - Annals of Internal Medicine, 2002 - Am Coll Physicians Economic Analysis of Influenza Vaccination and Antiviral Treatment ... Patrick
Y. Lee, MD; David B. Matchar, MD; Dennis A. Clements, MD, PhD; Joel Huber, PhD;
John D. Hamilton, MD; and Eric D. Peterson, MD, MPH Cited by 102 - Related articles - BL Direct - All 9 versions
MB Rothberg, DN Rose - The American journal of medicine, 2005 - Elsevier In the base case analysis, the majority of costs incurred for all strategies
were related to lost productivity from influenza illness. The least expensive
strategy varied from year to year. For the 10-year period, antiviral ... Cited by 36 - Related articles - All 14 versions
- ►pceo.org [PDF] PA Muennig, K Khan - Clinical Infectious Diseases, 2001 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 53 - Related articles - BL Direct - All 9 versions
- ►angrylapdog.com KL Nichol - Archives of Internal Medicine, 2001 - archinte.ama-assn.org.p.angrylapdog.com You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 197 - Related articles - Cached - BL Direct - All 10 versions
KL Nichol, KP Mallon, PM Mendelman - Vaccine, 2003 - Elsevier Methods: This cost benefit analysis was based on the results of a multi-center,
randomized, double blind placebo controlled trial that assessed the clinical
effectiveness of LAIV in healthy working adults. Outcomes from the trial ... Cited by 98 - Related articles - All 4 versions
D Sources, T Horizon - Annals of internal medicine, 2003 - Am Coll Physicians Background: Although antiviral therapy is cost-effective in adults, its
cost-effectiveness in older adults has not been studied. Objective: To determine
the cost-effectiveness of influenza test- ing and treatment strategies for ... Cited by 50 - Related articles - BL Direct - All 6 versions
KJ Smith, MS Roberts - The American journal of medicine, 2002 - Elsevier To estimate the cost-effectiveness of these newer interventions, we used a
decision model that compared several influenza management strategies: no testing
or treatment, amantadine or rimantadine treatment without testing, testing ... Cited by 47 - Related articles - All 7 versions
PA Scuffham, PA West - Vaccine, 2002 - Elsevier We compared the cost-effectiveness of different strategies for the control and
management of influenza for the elderly populations in three European countries
(England and Wales, France, Germany). A “no intervention” scenario was ... Cited by 58 - Related articles - All 6 versions
V Kumpulainen, M Mäkelä - Scandinavian journal of infectious diseases, 1997 - informahealthcare.com The cost of influenza vaccination and influenza infections was evaluated in a
controlled study among healthy municipal homemakers. Acute respiratory
infections were followed clinically and with laboratory samples for 8 ... Cited by 53 - Related articles - BL Direct - All 5 versions
- ►nih.gov MB Rothberg, S He, DN Rose - Journal of General Internal Medicine, 2003 - Springer OBJECTIVE: To determine the cost-effectiveness of rapid diag- nostic testing and
empiric antiviral therapy for healthy adults with symptoms of influenza. DESIGN:
Cost-effectiveness analysis using a decision model based on previously ... Cited by 22 - Related articles - BL Direct - All 11 versions
